Research Paper Describes Smart Contact Lens for Glaucoma Treatment and Diagnosis

A research paper published on Wednesday introduces a smart contact lens designed for glaucoma patients. The lens combines diagnostic monitoring with therapeutic delivery to address intraocular pressure, a key factor in glaucoma progression. Glaucoma is a leading cause of irreversible blindness, impacting over 80 million people globally according to the World Health Organization.

The contact lens incorporates sensors to continuously track intraocular pressure levels. When elevated pressure is detected, the lens releases medication directly to the eye. Researchers tested the prototype in laboratory settings and animal models, reporting stable performance over extended wear periods.

The study was conducted by a team from Seoul National University and published in the journal ACS Nano.

The lens uses wireless technology powered by tear fluid or external sources to operate without batteries. Initial results showed accurate pressure readings and controlled drug release in response to pressure changes. Glaucoma patients typically require daily eye drops for treatment, but adherence is low, with studies indicating only about 50% compliance.

This lens could offer a passive alternative, potentially reducing the need for frequent applications. The research highlights the device's biocompatibility, with no adverse effects observed in tests.

The technology targets early-stage glaucoma, where timely intervention can prevent vision loss.

Affected individuals include older adults and those with risk factors like high blood pressure or family history. Regulatory approval from bodies such as the FDA would be required before clinical use in humans. Future research will focus on human trials to validate safety and efficacy.

The paper notes challenges in scaling production and ensuring long-term comfort. If successful, the lens could integrate with smartphone apps for data tracking by healthcare providers.